BioAdaptives Inc. BDPT
0.00 USD 0.00 (+0.00%)
Nov 4, 2026, 10:10 AM EST
0.0016 Day range 0.0018
0.0009 52-week range 0.045
- YTD
- -92.31%
- 1 year
- -95.20%
- Market cap
- 334.77K
- EPS (ttm)
- -0.1102
- P/E ratio
- -0.02
- YTD return
- -92.31%
- 1-year return
- -95.20%
- Volume
- 3.78M
- Avg volume
- 20.31M
- Open
- 0.001776
- Previous close
- 0.0017
- Day's range
- 0.0016 – 0.0018
- 52-week range
- 0.0009 – 0.045
2Y -0.0508 (-96.76%)
News
BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video 
BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress 
UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM) 
BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update 
BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal 
BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula 
BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor 
BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform 
BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches 
BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness
Your note
Sign in to keep a note on BDPT — it syncs with the Stock Master app.